New Compounds with Bioisosteric Replacement of Classic Choline Kinase Inhibitors Show Potent Antiplasmodial Activity

In the fight against Malaria, new strategies need to be developed to avoid resistance of the parasite to pharmaceutics and other prevention barriers. Recently, a Host Directed Therapy approach based on the suppression of the starting materials uptake from the host by the parasite has provided excellent results. In this article, we propose the synthesis of bioisosteric compounds that are capable of inhibiting Plasmodium falciparum Choline Kinase and therefore to reduce choline uptake, which is essential for the development of the parasite. Of the 41 bioisosteric compounds reported herein, none showed any influence of the linker on the antimalarial and enzyme inhibitory activity, whereas an effect of the type of cationic heads used could be observed. SARs determined that the thienopyrimidine substituted in 4 by a pyrrolidine is the best scaffold, independently of the chosen linker. The decrease in lipophilicity seems to improve the antimalarial activity but to cause an opposite effect on the inhibition of the enzyme. While potent compounds with similar good inhibitory values have been related to the proposed mechanism of action, some of them still show discrepancies and further studies are needed to determine their specific molecular target.

[1]  A. Unciti-Broceta,et al.  Novel Purine Chemotypes with Activity against Plasmodium falciparum and Trypanosoma cruzi , 2021, Pharmaceuticals.

[2]  R. Esmaeili,et al.  Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis. , 2021, European journal of medicinal chemistry.

[3]  G. Viola,et al.  Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism. , 2020, European journal of medicinal chemistry.

[4]  T. M. Belete.  Recent Progress in the Development of New Antimalarial Drugs with Novel Targets , 2020, Drug design, development and therapy.

[5]  Chuangye Yan,et al.  Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum , 2020, Cell.

[6]  I. Tsoneva,et al.  Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti-Breast Cancer (MDA-MB-231, MCF-7) Agents. , 2020, Anti-cancer agents in medicinal chemistry.

[7]  E. Parisini,et al.  Crystal Structure of the Apo and the ADP-Bound Form of Choline Kinase from Plasmodium falciparum , 2020, Crystals.

[8]  T. Willson,et al.  A Chemical Probe for Dark Kinase STK17B Derives Its Potency and High Selectivity through a Unique P-Loop Conformation. , 2020, Journal of medicinal chemistry.

[9]  Wen-en Zhao,et al.  Discovery of new thieno[3,2-d]pyrimidine derivatives targeting EGFRL858R/T790M NSCLCs by the conformation constrained strategy. , 2020, European journal of medicinal chemistry.

[10]  K. Itami,et al.  Rapid Access to Kinase Inhibitor Pharmacophores by Regioselective C-H Arylation of Thieno[2,3-d]pyrimidine. , 2020, Organic letters.

[11]  A. Brancale,et al.  Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors. , 2019, Journal of medicinal chemistry.

[12]  L. C. López-Cara,et al.  1,2-Diphenoxiethane salts as potent antiplasmodial agents. , 2018, Bioorganic & medicinal chemistry letters.

[13]  G. Viola,et al.  Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors. , 2018, Future medicinal chemistry.

[14]  D. Wirth,et al.  Lysophosphatidylcholine Regulates Sexual Stage Differentiation in the Human Malaria Parasite Plasmodium falciparum , 2017, Cell.

[15]  G. Basso,et al.  Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1) , 2016, Scientific Reports.

[16]  Olga Genilloud,et al.  Discovery of New Compounds Active against Plasmodium falciparum by High Throughput Screening of Microbial Natural Products , 2016, PloS one.

[17]  G. Basso,et al.  New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1. , 2015, Future medicinal chemistry.

[18]  L. C. López-Cara,et al.  New non-symmetrical choline kinase inhibitors. , 2013, Bioorganic & medicinal chemistry.

[19]  A. Velázquez‐Campoy,et al.  Determination of Potential Scaffolds for Human Choline Kinase α1 by Chemical Deconvolution Studies , 2013, Chembiochem : a European journal of chemical biology.

[20]  A. Velázquez‐Campoy,et al.  The mechanism of allosteric coupling in choline kinase α1 revealed by the action of a rationally designed inhibitor. , 2013, Angewandte Chemie.

[21]  H. Vial,et al.  Choline Analogues in Malaria Chemotherapy , 2012, Current pharmaceutical design.

[22]  H. Vial,et al.  Glycerophospholipid acquisition in Plasmodium - a puzzling assembly of biosynthetic pathways. , 2010, International journal for parasitology.

[23]  Choukri Ben Mamoun,et al.  Targeting the lipid metabolic pathways for the treatment of malaria , 2009, Drug development research.

[24]  Jan Balzarini,et al.  Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization. , 2007, Journal of medicinal chemistry.

[25]  Terry K. Smith,et al.  Edinburgh Research Explorer Plasmodium Falciparum Choline Kinase Inhibition Leads to a Major Decrease in Phosphatidylethanolamine Causing Parasite Death , 2022 .

[26]  L. M. Lima,et al.  Bioisosterism: a useful strategy for molecular modification and drug design. , 2005, Current medicinal chemistry.